Toxicological and pharmacological concerns on oxidative stress and related diseasesSAEIDNIA, Soodabeh; ABDOLLAHI, Mohammad.Toxicology and applied pharmacology. 2013, Vol 273, Num 3, pp 442-455, issn 0041-008X, 14 p.Article

Bis selenide alkene derivatives : A class of potential antioxidant and antinociceptive agentsSAVEGNAGO, Lucielli; JESSE, Cristiano R; MORO, Angélica V et al.Pharmacology, biochemistry and behavior. 2006, Vol 83, Num 2, pp 221-229, issn 0091-3057, 9 p.Article

Apoptosis - From signalling pathways to therapeutic toolsDIEDERICH, Marc; GIELEN, Jacques; PIETTE, Jacques et al.Biochemical pharmacology. 2003, Vol 66, Num 8, issn 0006-2952, 357 p.Conference Proceedings

Notions de base de pharmacologie. I: Les étapes du développement d'un médicament = PharmacologyBENTUE-FERRER, D; LACROIX, P; REYMANN, J. M et al.Angéiologie (Paris). 1995, Vol 47, Num 3, pp 43-52, issn 0003-3049Article

Cicletanine: biology, pharmacology and clinical sciencesBRAQUET, P; GUINOT, P; TARRADE, T et al.Drugs under experimental and clinical research. 1988, Vol 14, Num 2-3, pp 71-230, issn 0378-6501Serial Issue

Review of clinical and laboratory experiences with molindone hydrochlorideCLAGHORN, J. L.The Journal of clinical psychiatry. 1985, Vol 46, Num 8, pp 30-33, issn 0160-6689Article

Physiological and pharmacological properties of vanadiumJANDHYALA, B. S; HOM, G. J.Life sciences (1973). 1983, Vol 33, Num 14, pp 1325-1340, issn 0024-3205Article

p73 and p63 protein stability: the way to regulate function?MAISSE, Carine; GUERRIERI, Piero; MELINO, Gerry et al.Biochemical pharmacology. 2003, Vol 66, Num 8, pp 1555-1561, issn 0006-2952, 7 p.Conference Paper

6'7'-Dihydroxybergamottin contributes to the grapefruit juice effectKAKAR, Shefali M; PAINE, Mary F; STEWART, Paul W et al.Clinical pharmacology and therapeutics. 2004, Vol 75, Num 6, pp 569-579, issn 0009-9236, 11 p.Article

II: Pharmacologie des salicylés = II: Pharmacology of salicylatesBANNWARTH, B; NETTER, P; MONOT, C et al.Concours médical (Paris). 1984, Vol 106, Num 35, pp 3375-3381, issn 0010-5309, 5 p.Article

Morphine et morphiniques. Introduction = Morphine and morphinics. IntroductionTANNIERES-RUFFIE, M.-L; LEVANTE, A.La Revue du praticien (Paris). 1983, Vol 33, Num 7, issn 0035-2640, 277Article

Pharmacologie de la morphine et des morphinomimétiques = Pharmacological study of morphine and morphinomimeticsANDREJAK, M; SCHMITT, H.La Revue du praticien (Paris). 1983, Vol 33, Num 7, pp 279-290, issn 0035-2640Article

Pharmacologic properties of CDB(VA)-2914GAINER, Erin E; ULMANN, André.Steroids. 2003, Vol 68, Num 10-13, pp 1005-1011, issn 0039-128X, 7 p.Conference Paper

Control Yourself: Alcohol and ImpulsivityPOTENZA, Marc N; DE WIT, Harriet.Alcoholism, clinical and experimental research. 2010, Vol 34, Num 8, pp 1303-1305, issn 0145-6008, 3 p.Article

The Pharmacology of Lysergic Acid Diethylamide : A ReviewPASSIE, Torsten; HALPERN, John H; STICHTENOTH, Dirk O et al.CNS neuroscience & therapeutics (Print). 2008, Vol 14, Num 4, pp 295-314, issn 1755-5930, 20 p.Article

Abstract Book 2011 European Multidisciplinary Cancer Congress (ECCO16, ESMO36, ESTRO30): integrating basic & translational science, surgery, radiotherapy, medical oncology, advocacy & care, Stockholm, 23-27 September 2011European journal of cancer. Supplement (1990). 2011, Vol 47, Num 1, issn 1359-6349, 773 p.Conference Proceedings

Moving Forward with New Data and Approaches: A Fresh Look at Anthracyclines in Breast Cancer. Summary of a workshop held in September 2010AMADORI, Dino; AAPRO, Matti.European journal of cancer. Supplement (1990). 2011, Vol 9, Num 2, issn 1359-6349, 44 p.Serial Issue

Improving outcome by targeted delivery in Breast Cancer: A review of nab^TM-paclitaxel (nanoparticle albumin-bound paclitaxel)European journal of cancer. Supplement (1990). 2010, Vol 8, Num 1, issn 1359-6349, 20 p.Serial Issue

EBCC 7: European Breast Cancer Conference, 24-27 March 2010, Barcelona , SpainEuropean journal of cancer. Supplement (1990). 2010, Vol 8, Num 3, issn 1359-6349, 276 p.Conference Proceedings

Evolving options and future challenges for targeted therapies in ErbB2 (HER2)-positive breast cancerEuropean journal of cancer. Supplement (1990). 2008, Vol 6, Num 5, issn 1359-6349, 32 p.Serial Issue

Cancer Prevention 2006 - Advances in Molecular and Clinical aspects of cancer preventionEuropean journal of cancer. Supplement (1990). 2006, Vol 4, Num 1, issn 1359-6349, 72 p.Conference Proceedings

Cancer stem cells: opportunities for novel diagnostics and drug discoveryKEITH, W. Nicol.European journal of cancer (1990). 2006, Vol 42, Num 9, issn 0959-8049, 122 p.Serial Issue

Cancer in children and adolescents in EuropeSTELIAROVA-FOUCHER, Eva; COEBERGH, Jan Willem; KAATSCH, Peter et al.European journal of cancer (1990). 2006, Vol 42, Num 13, issn 0959-8049, 281 p.Serial Issue

Cancer chemoprevention - An update on a novel and exciting field of oncologyGESCHER, Andreas.European journal of cancer (1990). 2005, Vol 41, Num 13, issn 0959-8049, 205 p.Serial Issue

British pharmaceutial [sic] conference (Science proceedings, Manchester, September 26-28, 2005)Craig, Duncan.Journal of pharmacy and pharmacology. Supplement. 2005, issn 0373-1022, 1Vol, XVI-122 pConference Proceedings